series-c-plus
Stage
4
Investors
About
Congenica provides a clinical-grade genomic interpretation platform that analyzes DNA sequencing data to help clinicians and diagnostic labs prioritize, interpret genetic variants, and generate clinical reports supporting decision-making.
Explore Congenica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.